目的 探究喜炎平注射液聯(lián)合氨溴特羅口服溶液治療小兒支氣管肺炎的臨床療效。方法 選取2014年10月-2015年10月在成都市溫江區(qū)人民醫(yī)院接受治療的小兒支氣管肺炎患兒96例，所有患者按治療方法的不同分為對(duì)照組和治療組，每組各48例。對(duì)照組口服氨溴特羅口服溶液，年齡<8個(gè)月：2.5 mL/次；8個(gè)月≤年齡≤12個(gè)月：5 mL/次；年齡>12個(gè)月：7.5 mL/次；3次/d。治療組在對(duì)照組基礎(chǔ)之上靜脈輸注喜炎平注射液，喜炎平注射液需加入到5%的葡萄糖溶液中進(jìn)行輸注，年齡<6個(gè)月：1～1.5 mL/次，6個(gè)月≤年齡≤12個(gè)月：1.5～2.0 mL/次，1歲 < 年齡≤3歲：2.0～3.0 mL/次，3歲 < 年齡≤6歲：3.0～4.0 mL/次，6歲 < 年齡≤13歲：4.0～6.0 mL/次，1次/d。兩組患兒連續(xù)治療7 d。觀察兩組的臨床療效，比較兩組患者的臨床指標(biāo)情況。結(jié)果 治療后，對(duì)照組和治療組的總有效率分別為83.33%、95.83%，兩組比較差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。治療后，治療組患兒咳嗽消失時(shí)間、咳痰消失時(shí)間、肺部濕啰音消失時(shí)間、呼吸頻率及氧飽和度改善均優(yōu)于對(duì)照組，兩組比較差異具有統(tǒng)計(jì)學(xué)意義（P<0.05）。結(jié)論 喜炎平注射液聯(lián)合氨溴特羅口服溶液治療小兒支氣管肺炎具有較好的臨床療效，能明顯縮短癥狀消失時(shí)間，提高患兒氧飽和度，具有一定的臨床推廣應(yīng)用價(jià)值。

Objective To investigate clinical effect of Xiyanping Injection combined with Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution in treatment of children with bronchial pneumonia. Methods Children (96 cases) with bronchial pneumonia in Chengdu Wenjiang District People's Hospital from October 2013 to October 2015 were enrolled in this study. According to the different treatment plans, children were randomly divided into control and treatment groups, and each group had 48 cases. Children in the control group were po administered with Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution, age <8 months:2.5 mL/time, 8 months≤age≤12 months:5 mL/times, age >12 months:7.5 mL/time, three times daily. Children in the treatment group were iv administered with Xiyanping Injection on the basis of the control group, Xiyanping Injection added to 5% glucose solution, age <6 months:1-1.5 mL/time, 6 months≤age≤12 months:1.5-2.0 mL/time, 1 year≤age≤3 years:2.0-3.0 mL/time, 3 year≤age≤6 years:3.0-4.0 mL/time, 6 year≤age≤13 years:4.0-6.0 mL/time, once daily. Children in two groups were treatment for 7 d. After treatment, the clinical efficacies were evaluated, and the clinical indexes in two groups were compared. Results After treatment, the clinical efficacies in the control and treatment groups were 83.33% and 95.83%, respectively, and there was difference between two groups (P<0.05). After treatment, the improvement of cough disappearance time, expectoration disappearance time, lung wet rales disappearance time, respiratory rate, and oxygen saturation in the treatment group were significantly better than those in the control group, with significant difference between two groups. Conclusion Xiyanping Injection combined with Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution has clinical curative effect in treatment of children with bronchial pneumonia, and can significantly shorten symptom disappearance time and increase oxygen saturation, which has a certain clinical application value.